ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Armata Pharmaceuticals, Inc. (ARMP) shows an Average True Range (ATR) of 0.15 and an Enterprise Value of 197.22M. Its average trading volume over the past 3 months is 233.42K, indicating liquidity. These fundamental metrics provide insight into ARMP's underlying financial health and market activity.
Armata Pharmaceuticals, Inc. (ARMP) technical indicators as of August 1, 2025: the SMA 20 is 4.96%, SMA 50 at 15.52%, and SMA 200 at 23.72%. The RSI 14 value is 61.32, suggesting its current momentum. These technical analysis signals help assess ARMP's price trends and potential future movements.
Armata Pharmaceuticals, Inc. (ARMP) stock performance overview as of August 1, 2025: The 52-week high is $2.96 (currently -17.91% below), and the 52-week low is $0.898 (currently 172.8% above). Over the past year, ARMP's performance is -15.81%, compared to the S&P 500's 14.84% change.
According to market data, Armata Pharmaceuticals, Inc. (ARMP) stock's recent performance metrics show that over the last month, ARMP is 29.63%, with a Year-to-Date (YTD) performance of 32.43%. Over the past year, the stock has seen a -15.81% change. These figures summarize ARMP's price movements across various periods, reflecting its historical returns.
According to current financial data, ARMP stock's P/E (TTM) ratio is -208.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ARMP, including P/S (71.80), P/B (-1.65), and P/FCF (-2.44), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.